Overview

Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression

Status:
Completed
Trial end date:
2024-03-30
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the acute and subacute effects of an inhaled N, N-Dimethyltryptamine (DMT) in patients with partial response in depression.
Phase:
Phase 2
Details
Lead Sponsor:
Universidade Federal do Rio Grande do Norte
Treatments:
N,N-Dimethyltryptamine